Background No therapy is approved for COVID-19 pneumonia. The aim of this study was to
assess the role of tocilizumab in reducing the risk of invasive mechanical ventilation and …

The immune system of patients infected by SARS-CoV-2 is severely impaired. Detailed
investigation of T cells and cytokine production in patients affected by COVID-19 pneumonia are …

Background Few small studies have described hospital-acquired infections (HAIs) occurring
in patients with COVID-19. Research Question What characteristics in critically ill patients …

In patients infected by SARS‐CoV‐2 who experience an exaggerated inflammation leading
to pneumonia, monocytes likely play a major role but have received poor attention. Thus, we …

Background A growing body of observational evidence supports the value of ceftazidime-avibactam
(CAZ-AVI) in managing infections caused by carbapenem-resistant …

Background Patients with COVID-19 experience multiple clinical conditions that may cause
electrolyte imbalances. Hypokalemia is a concerning electrolyte disorder closely associated …

Introduction A hypercoagulable condition was described in patients with coronavirus disease
2019 (COVID-19) and proposed as a possible pathogenic mechanism contributing to …

Studies on the interactions between SARS‐CoV‐2 and humoral immunity are fundamental
to elaborate effective therapies including vaccines. We used polychromatic flow cytometry, …

Purpose Cytomegalovirus (CMV) reactivation in immunocompetent critically ill patients is
common and relates to a worsening outcome. In this large observational study, we evaluated …

Objectives We aimed to develop and validate a risk score to predict severe respiratory failure
(SRF) among patients hospitalized with coronavirus disease-2019 (COVID-19). Methods …